BUCCOLIERO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 357
EU - Europa 188
AS - Asia 48
OC - Oceania 1
SA - Sud America 1
Totale 595
Nazione #
US - Stati Uniti d'America 357
RU - Federazione Russa 89
IT - Italia 32
IE - Irlanda 28
SG - Singapore 21
SE - Svezia 16
HK - Hong Kong 13
GB - Regno Unito 8
FI - Finlandia 6
JO - Giordania 6
DE - Germania 5
CN - Cina 3
IN - India 3
BE - Belgio 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
KR - Corea 1
NL - Olanda 1
TR - Turchia 1
Totale 595
Città #
Santa Clara 84
Fairfield 33
Chandler 29
Dublin 28
Ashburn 24
Singapore 19
Ann Arbor 15
Cambridge 14
Houston 13
Woodbridge 13
Florence 12
Lawrence 12
Seattle 12
Altamura 11
Boardman 7
Medford 7
Hong Kong 6
New York 6
Princeton 6
Wilmington 6
Jacksonville 4
Brussels 2
Falls Church 2
London 2
Mumbai 2
San Diego 2
Scandicci 2
Andover 1
Bern 1
Boston 1
Bremen 1
Grevenbroich 1
Hanover 1
Islington 1
Izmir 1
Melbourne 1
Moscow 1
Munich 1
Porto Alegre 1
Prescot 1
Pune 1
Seoul 1
Shanghai 1
Washington 1
Totale 390
Nome #
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 154
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. 93
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma 91
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 71
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model 70
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma 67
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 51
Totale 597
Categoria #
all - tutte 1.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 0 6 7 7 6 6 4 2 1
2020/202125 7 1 1 2 1 2 1 1 3 3 3 0
2021/202235 1 5 0 5 1 1 2 1 2 1 2 14
2022/2023131 11 27 6 10 13 18 18 5 18 0 4 1
2023/202457 9 2 7 5 8 10 0 6 0 1 7 2
2024/2025228 17 34 23 49 105 0 0 0 0 0 0 0
Totale 597